Condition
Stage IV Fallopian Tube Cancer AJCC v8 clinical trials and research
Research outlook What's coming for Ovarian cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 4 Stage IV Fallopian Tube Cancer AJCC v8 clinical trials that are recruiting, at sites in 5 countries (most in United States (4), Canada (1), Italy (1)). By phase: Phase 1 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 5Countries
Newest Stage IV Fallopian Tube Cancer AJCC v8 clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Automated physical activity program for cancer patients | — | Buffalo, New York | Recruiting | Mar 4, 2025 |
| Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors | Phase 1 | Houston, Texas | Recruiting | Oct 25, 2021 |
| Minimally invasive surgery for advanced ovarian cancer after chemotherapy | Phase 3 | Miami, Florida and 18 other locations | Recruiting | Oct 5, 2020 |
| Combining talazoparib with radiation therapy for recurrent gynecologic cancers | Phase 1 | Baltimore, Maryland and 1 other locations | Recruiting | May 30, 2019 |
All recruiting trials (4)
-
Automated physical activity program for cancer patients
This study is testing whether a personalized exercise program using wearable technology can help cancer patients be more active compared to regular exercise advice.
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Minimally invasive surgery for advanced ovarian cancer after chemotherapy
This study is testing if a less invasive surgery is just as effective as traditional surgery for women with advanced ovarian cancer after they have had chemotherapy.
-
Combining talazoparib with radiation therapy for recurrent gynecologic cancers
This study is testing if combining a drug called talazoparib with radiation therapy can safely help people with recurrent gynecologic cancers feel better.
Related topics
Quick answers
How many Stage IV Fallopian Tube Cancer AJCC v8 clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (4 trials), Canada (1 trial), Italy (1 trial), Mexico (1 trial), Netherlands (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.